Yadgarov Arkadiy, Liu Dan, Crane Elliot S, Khouri Albert S
Resident, Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, New Jersey USA.
Student, Institute of Ophthalmology and Visual Science, New Jersey Medical School, Rutgers University, Newark, New Jersey USA.
J Curr Glaucoma Pract. 2017 Jan-Apr;11(1):16-21. doi: 10.5005/jp-journals-10008-1215. Epub 2017 Jan 18.
To describe postoperative surgical success of either Ahmed or Baerveldt tube shunt implantation for eyes with medically uncontrolled traumatic glaucoma.
A review was carried out to identify patients with traumatic glaucoma that required tube shunt implantation between 2009 and 2015 at Rutgers University in Newark, New Jersey, USA. Seventeen eyes from 17 patients met inclusion criteria, including at least 3-month postoperative follow-up. The main outcome measure was surgical success at 1-year follow-up after tube implantation.
Mean preoperative intraocular pressure (IOP) was 34.1 ± 8.2 mm Hg on 3.1 ± 1.6 ocular hypotensive medications. Nine eyes (53%) sustained closed globe injury. Ten eyes (59%) received an Ahmed valve shunt and seven eyes (41%) received a Baerveldt tube shunt. Surgical success rate at 1 year postoperatively was 83%. Compared to preoperative, the mean postoperative IOP was significantly lower (16.1 ± 3.5 mm Hg, p < 0.001) on significantly fewer ocular hypertensive medications (1.3 ± 1.6, p = 0.001) at a mean follow-up of 10 months. Mean IOP reduction at last follow-up was 49%. There were three cases of surgical failures: One case of hypotony, one case of tube extrusion with subsequent explan-tation, and one case requiring second tube insertion for IOP control.
Implantation of an Ahmed or Baerveldt tube shunt provided successful control of IOP in patients with medically uncontrollable traumatic glaucoma.
Yadgarov A, Liu D, Crane ES, Khouri AS. Surgical Outcomes of Ahmed or Baerveldt Tube Shunt Implantation for medically Uncontrolled Traumatic Glaucoma. J Curr Glaucoma Pract 2017;11(1):16-21.
描述艾哈迈德(Ahmed)或贝尔维尔德(Baerveldt)引流管植入术治疗药物治疗无效的外伤性青光眼患者术后的手术成功率。
进行一项回顾性研究,以确定2009年至2015年期间在美国新泽西州纽瓦克市罗格斯大学需要进行引流管植入术的外伤性青光眼患者。17例患者的17只眼符合纳入标准,包括至少3个月的术后随访。主要观察指标为引流管植入术后1年的手术成功率。
术前平均眼压(IOP)为34.1±8.2mmHg,使用3.1±1.6种降眼压药物。9只眼(53%)为闭合性眼球损伤。10只眼(59%)接受了艾哈迈德瓣膜引流管植入,7只眼(41%)接受了贝尔维尔德引流管植入。术后1年的手术成功率为83%。与术前相比,平均随访10个月时,术后平均眼压显著降低(16.1±3.5mmHg,p<0.001),使用的降眼压药物显著减少(1.3±1.6种,p=0.001)。最后一次随访时平均眼压降低了49%。有3例手术失败:1例低眼压,1例引流管脱出并随后进行了巩膜瓣覆盖术,1例需要再次植入引流管以控制眼压。
艾哈迈德或贝尔维尔德引流管植入术成功控制了药物治疗无效的外伤性青光眼患者的眼压。
Yadgarov A, Liu D, Crane ES, Khouri AS. Ahmed或Baerveldt引流管植入术治疗药物治疗无效的外伤性青光眼的手术结果[J]. 当代青光眼实践杂志, 2017;11(1):16-21.